Trial intelligence / Profile preview

Cefalotin prophylaxis in reduction mammoplasty

RBR-3jtgfhRecruiting

Sponsor
Hospital Agamenon Magalhães
Start
Jan 2015
Modality
Small Molecules
Countries
1
01

Overview

Open-label trial of cefalotin in surgical site infection (SSI) (2 arms), sponsored by Hospital Agamenon Magalhães. Started Jan 2015; status: recruiting.

02

Drugs

cefalotin
03

Conditions

surgical site infection (SSI)

Beyond the preview

Go deeper on RBR-3jtgfh.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on RBR-3jtgfh.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call